Cellular and T cell engager Immunotherapy
Cytokine Release Syndrome in Patients Receiving Alternative Step-Up Doses of Talquetamab for Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study
Paula Rodríguez-Otero, MD, PhD (she/her/hers)
Associate Professor
Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain
Pamplona, Navarra, Spain